Rations of Ilumina (ILMN) dropped as the Federal Trade Commission (FTC) ordered the biotech firm to unwind its purchase of cancer investigation provider GRAIL.
Check Also
New Acting CFPB Chief Halts Investigations and Enforcements, Forgoes Some Federal Funding
Tierney L. Crusty / Bloomberg via Getty Images Key Takeaways Russell Vought took over as …